FDMT
Price
$8.10
Change
+$0.20 (+2.53%)
Updated
Dec 24 closing price
Capitalization
462.79M
64 days until earnings call
Intraday BUY SELL Signals
IDYA
Price
$35.68
Change
+$0.27 (+0.76%)
Updated
Dec 24 closing price
Capitalization
3.13B
96 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FDMT vs IDYA

Header iconFDMT vs IDYA Comparison
Open Charts FDMT vs IDYABanner chart's image
4D Molecular Therapeutics
Price$8.10
Change+$0.20 (+2.53%)
Volume$613.91K
Capitalization462.79M
IDEAYA Biosciences
Price$35.68
Change+$0.27 (+0.76%)
Volume$355.13K
Capitalization3.13B
FDMT vs IDYA Comparison Chart in %
FDMT
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FDMT vs. IDYA commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and IDYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (FDMT: $8.10 vs. IDYA: $35.68)
Brand notoriety: FDMT and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 58% vs. IDYA: 35%
Market capitalization -- FDMT: $462.79M vs. IDYA: $3.13B
FDMT [@Biotechnology] is valued at $462.79M. IDYA’s [@Biotechnology] market capitalization is $3.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 1 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 1 green, 4 red.
According to our system of comparison, IDYA is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 4 TA indicator(s) are bullish while IDYA’s TA Score has 3 bullish TA indicator(s).

  • FDMT’s TA Score: 4 bullish, 5 bearish.
  • IDYA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both FDMT and IDYA are a bad buy in the short-term.

Price Growth

FDMT (@Biotechnology) experienced а -12.05% price change this week, while IDYA (@Biotechnology) price change was +5.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

FDMT is expected to report earnings on Feb 27, 2026.

IDYA is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($3.13B) has a higher market cap than FDMT($463M). FDMT YTD gains are higher at: 45.422 vs. IDYA (38.833). IDYA has higher annual earnings (EBITDA): -204.84M vs. FDMT (-222.95M). IDYA has more cash in the bank: 787M vs. FDMT (305M). FDMT has less debt than IDYA: FDMT (22.3M) vs IDYA (27.2M). IDYA has higher revenues than FDMT: IDYA (215M) vs FDMT (120K).
FDMTIDYAFDMT / IDYA
Capitalization463M3.13B15%
EBITDA-222.95M-204.84M109%
Gain YTD45.42238.833117%
P/E RatioN/AN/A-
Revenue120K215M0%
Total Cash305M787M39%
Total Debt22.3M27.2M82%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
57
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FDMTIDYA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 8 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
FDMT
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CILGX16.230.06
+0.37%
Clarkston Institutional
THOIX47.660.12
+0.25%
Thornburg Global Opportunities I
AQGIX12.350.03
+0.24%
AQR Global Equity I
UIVNX12.720.03
+0.24%
MFS Intrinsic Value R2
GOIGX34.82-0.04
-0.11%
JHancock International Growth A

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with RGNX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+2.53%
RGNX - FDMT
48%
Loosely correlated
+0.77%
CLDX - FDMT
45%
Loosely correlated
+0.94%
IDYA - FDMT
44%
Loosely correlated
+0.76%
SYRE - FDMT
43%
Loosely correlated
-0.54%
KURA - FDMT
43%
Loosely correlated
+2.50%
More